FLGT
Fulgent Genetics, Inc. Common Stock (FLGT) Business Model
Review Fulgent Genetics, Inc. Common Stock (FLGT) business model with server-rendered company data, supporting context and links to related investor research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 0
- Annual revenue
- $322.67M
Fulgent Genetics, Inc. Common Stock (FLGT) Business Model research
Fulgent Genetics, Inc. Common Stock operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Review how the company generates revenue, the customers it serves and the resources required to sustain growth.
A durable business model should be evaluated through revenue quality, margins, cash conversion, competitive positioning and capital requirements. The financials and competitors sections provide the next steps for that assessment.